World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
58185
World Ranking
4871
National Ranking
2639

Nabeel Bardeesy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nabeel Bardeesy sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 318 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nabeel Bardeesy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nabeel Bardeesy sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nabeel Bardeesy is affiliated with Harvard University in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with a significant focus on Medicine. The main subfields of their work include Molecular Biology, Oncology, Cancer Research, Surgery, and Pulmonary and Respiratory Medicine.

The scientist's research covers several key topics:

  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • RNA modifications and cancer
  • Fibroblast Growth Factor Research
  • Peptidase Inhibition and Analysis
  • Epigenetics and DNA Methylation
  • Cancer Genomics and Diagnostics

Nabeel Bardeesy has contributed to numerous scientific publications, many of which appear in high-profile venues. Frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Cancer Research
  • Cancer Discovery
  • Nature Communications

Recent notable papers include:

  • "Immunology and immunotherapy of cholangiocarcinoma," 2023, Nature Reviews Gastroenterology & Hepatology
  • "ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer," 2021, Nature Cancer
  • "Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway," 2023, Cell
  • "The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer," 2022, Annals of Oncology
  • "Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer," 2021, Nature Nanotechnology

The scientist collaborates frequently with other researchers, including:

  • Lei Shi
  • Kwok-Kin Wong
  • Vikram Deshpande
  • Meng-Ju Wu
  • Vindhya Vijay

Best Publications

  • The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

    Reuben J. Shaw;Reuben J. Shaw;Katja A. Lamia;Debbie Vasquez;Seung Hoi Koo;Seung Hoi Koo

  • The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

    Reuben J. Shaw;Monica Kosmatka;Nabeel Bardeesy;Rebecca L. Hurley

  • Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

    Benjamin J. Raphael;Ralph H. Hruban;Andrew J. Aguirre;Richard A. Moffitt

  • Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway

    Jaekyoung Son;Costas A. Lyssiotis;Costas A. Lyssiotis;Haoqiang Ying;Xiaoxu Wang

  • Pancreatic cancers require autophagy for tumor growth

    Shenghong Yang;Xiaoxu Wang;Gianmarco Contino;Marc Liesa

  • Pancreatic cancer biology and genetics

    Nabeel Bardeesy;Ronald A. DePinho

  • The LKB1 tumor suppressor negatively regulates mTOR signaling

    Reuben J Shaw;Nabeel Bardeesy;Brendan D Manning;Lyle Lopez

  • LKB1 modulates lung cancer differentiation and metastasis

    Hongbin Ji;Matthew R. Ramsey;D. Neil Hayes;Cheng Fan

  • Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

    Andrew J. Aguirre;Nabeel Bardeesy;Manisha Sinha;Lyle Lopez

  • Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.

    Norman E. Sharpless;Nabeel Bardeesy;Kee Ho Lee;Daniel Carrasco

  • Essential role for oncogenic Ras in tumour maintenance

    Lynda Chin;Alice Tam;Alice Tam;Jason Pomerantz;Michelle Wong

  • Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

    Dawang Zhou;Claudius Conrad;Fan Xia;Ji Sun Park

  • Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner

    Adem Kalender;Anand Selvaraj;Anand Selvaraj;So Young Kim;So Young Kim;Pawan Gulati

  • A gene expression signature associated with “K-Ras addiction” reveals regulators of EMT and tumor cell survival

    Anurag Singh;Patricia Greninger;Daniel Rhodes;Louise Koopman

  • Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

    Triantafyllos Stylianopoulos;John D. Martin;John D. Martin;Vikash P. Chauhan;Saloni R. Jain;Saloni R. Jain

  • Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

    Nabeel Bardeesy;Kuang Hung Cheng;Justin H. Berger;Gerald C. Chu

  • Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.

    Rushika M. Perera;Svetlana Stoykova;Brandon N. Nicolay;Kenneth N. Ross

  • Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

    Nabeel Bardeesy;Andrew J. Aguirre;Gerald C. Chu;Kuang Hung Cheng

  • Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

    Michael N. Corradetti;Ken Inoki;Nabeel Bardeesy;Ronald A. DePinho

  • TGF-β Tumor Suppression Through A Lethal EMT

    Charles J. David;Yun Han Huang;Mo Chen;Jie Su

Frequent Co-Authors

Vikram Deshpande
Vikram Deshpande Harvard University
Ronald A. DePinho
Ronald A. DePinho The University of Texas MD Anderson Cancer Center
Kwok-Kin Wong
Kwok-Kin Wong New York University
Andrew X. Zhu
Andrew X. Zhu Harvard University
Cristina R. Ferrone
Cristina R. Ferrone Harvard University
Sridhar Ramaswamy
Sridhar Ramaswamy Harvard University
Norman E. Sharpless
Norman E. Sharpless National Institutes of Health
David T. Ting
David T. Ting Harvard University
Yujin Hoshida
Yujin Hoshida The University of Texas Southwestern Medical Center
Lynda Chin
Lynda Chin The University of Texas Health Science Center at Houston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine or a related field but aren't sure if the traditional path is right for you, there are a variety of online degree options to help you get started or advance your healthcare career. These programs offer flexibility, affordability, and diverse specialization opportunities.

Mental health is a fast-growing specialty in healthcare. Programs like the msn to pmhnp online are designed for nurses aiming to become Psychiatric Mental Health Nurse Practitioners through a convenient online format.

Students seeking an undergraduate degree can benefit from the cheapest online health science degree programs, which offer comprehensive foundational education while remaining budget-friendly. For professionals looking to move into leadership roles, the cheapest online master degree in healthcare administration can open doors to advanced career opportunities.

For registered nurses interested in the highest levels of clinical practice, the best online bsn to dnp programs provide a streamlined path to earning a Doctor of Nursing Practice degree online.

These related online degrees expand your options in medicine, letting you tailor your education and career to fit your goals and lifestyle.

Best Scientists Citing Nabeel Bardeesy

Trending Scientists

Recently Published Articles